S106 HIGH EFFICACY OF VENETOCLAX PLUS OBINUTUZUMAB IN PATIENTS WITH COMPLEX KARYOTYPE (CKT) AND CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): A PROSPECTIVE ANALYSIS FROM THE CLL14 TRIAL

Authors :: Karl-Anton Kreuzer
M. Patz
M. Porro Lurà
Barbara Eichhorst
Maneesh Tandon
Matthias Ritgen
Kathryn Humphrey
Othman Al-Sawaf
Kirsten Fischer
A. M. Fink
William Schary
E. Lilienweiss
Sandra Robrecht
Jasmin Bahlo
S. Stilgenbauer
E. Tasch
Yanwen Jiang
Michael Hallek
Source :: HemaSphere. 3:4-5
Publication Year :: 2019
Publisher :: Ovid Technologies (Wolters Kluwer Health), 2019.

Subjects :: Oncology
medicine.medical_specialty
business.industry
Venetoclax
Chronic lymphocytic leukemia
Hematology
medicine.disease
chemistry.chemical_compound
Prospective analysis
chemistry
Obinutuzumab
Internal medicine
Complex Karyotype
Medicine
In patient
business

Full Text Access

Tools